Radiopharm Theranostics Yönetim
Yönetim kriter kontrolleri 2/4
Radiopharm Theranostics' CEO is Riccardo Canevari, appointed in Sep 2021, has a tenure of 3.17 years. total yearly compensation is A$2.65M, comprised of 31.8% salary and 68.2% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth A$321.69K. The average tenure of the management team and the board of directors is 2.8 years and 2.6 years respectively.
Anahtar bilgiler
Riccardo Canevari
İcra Kurulu Başkanı
AU$2.7m
Toplam tazminat
CEO maaş yüzdesi | 31.8% |
CEO görev süresi | 3.2yrs |
CEO sahipliği | 0.6% |
Yönetim ortalama görev süresi | 2.8yrs |
Yönetim Kurulu ortalama görev süresi | 2.6yrs |
Son yönetim güncellemeleri
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | AU$3m | AU$844k | -AU$48m |
Mar 31 2024 | n/a | n/a | -AU$47m |
Dec 31 2023 | n/a | n/a | -AU$47m |
Sep 30 2023 | n/a | n/a | -AU$41m |
Jun 30 2023 | AU$3m | AU$825k | -AU$35m |
Mar 31 2023 | n/a | n/a | -AU$30m |
Dec 31 2022 | n/a | n/a | -AU$26m |
Sep 30 2022 | n/a | n/a | -AU$28m |
Jun 30 2022 | AU$3m | AU$631k | -AU$30m |
Tazminat ve Piyasa: Riccardo's total compensation ($USD1.74M) is above average for companies of similar size in the Australian market ($USD299.27K).
Tazminat ve Kazançlar: Riccardo's compensation has been consistent with company performance over the past year.
CEO
Riccardo Canevari
3.2yrs
Görev süresi
AU$2,652,983
Tazminat
Mr. Riccardo Canevari is Managing Director & Chief Executive Officer since September 13, 2021 and Director at Radiopharm Theranostics Limited. He was Chief Commercial Officer of Advanced Accelerator Applic...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Founder & Executive Chairman | 3.8yrs | AU$478.85k | 6.87% A$ 3.6m | |
MD, CEO & Director | 3.2yrs | AU$2.65m | 0.62% A$ 321.7k | |
CFO, Joint Company Secretary & Director | no data | AU$27.71k | 0.73% A$ 383.0k | |
Chief Operating Officer | 2.4yrs | AU$1.60m | Veri yok | |
Chief Business Officer | no data | AU$579.19k | 0.046% A$ 24.0k | |
Chief Medical Officer | less than a year | Veri yok | Veri yok | |
Joint Company Secretary | 3.1yrs | Veri yok | Veri yok |
2.8yrs
Ortalama Görev Süresi
68yo
Ortalama Yaş
Deneyimli Yönetim: RAD's management team is considered experienced (2.8 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Founder & Executive Chairman | 3.8yrs | AU$478.85k | 6.87% A$ 3.6m | |
MD, CEO & Director | no data | AU$2.65m | 0.62% A$ 321.7k | |
CFO, Joint Company Secretary & Director | less than a year | AU$27.71k | 0.73% A$ 383.0k | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Non-Executive Director | 3.6yrs | AU$476.52k | 0.23% A$ 118.9k | |
Non-Executive Director | 2.4yrs | AU$165.41k | 0.049% A$ 25.7k | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Non-Executive Director | 2.8yrs | AU$94.32k | 0.030% A$ 15.5k | |
Member of Scientific Advisory Board | 2.4yrs | Veri yok | Veri yok |
2.6yrs
Ortalama Görev Süresi
Deneyimli Yönetim Kurulu: RAD's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.